Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals

Virology

Volumn 415, Issue 2, 2011, Pages 160-167

  Dugast, Anne Sophie ^a   Tonelli, Andrew ^a   Berger, Christoph T ^a   Ackerman, Margaret E ^a   Sciaranghella, Gaia ^a   Liu, Qingquan ^a   Sips, Magdalena ^a   Toth, Ildiko ^a   Piechocka Trocha, Alicja ^a   Ghebremichael, Musie ^a,b   Alter, Galit ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Antibody dependent cellular phagocytosis; Fc receptors; HIV 1; Innate immunity

Indexed keywords

FC RECEPTOR; FC RECEPTOR I; FC RECEPTOR II; FC RECEPTOR IIIA; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR PHAGOCYTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MONOCYTE; MYELOID DENDRITIC CELL; OPSONIZATION; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL CLEARANCE;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CHRONIC DISEASE; FEMALE; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; MALE; PHAGOCYTES; PHAGOCYTOSIS; RECEPTORS, FC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79957766689     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.03.012     Document Type: Article

References (47)

1. Aasa-Chapman M.M., Holuigue S., Aubin K., Wong M., Jones N.A., Cornforth D., Pellegrino P., Newton P., Williams I., Borrow P., McKnight A. Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J. Virol. 2005, 79:2823-2830.
2. Alter G., Tsoukas C.M., Rouleau D., Cote P., Routy J.P., Sekaly R.P., Bernard N.F. Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection. AIDS 2004, 18:1979-1989.
3. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., Streeck H., Johnston M.N., Staller K.D., Zaman M.T., Yu X.G., Lichterfeld M., Basgoz N., Rosenberg E.S., Altfeld M. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
4. Anderson C.L. Structural and functional polymorphism of human Fc receptors for IgG. Chem. Immunol. 1989, 47:1-20.
5. Arend W.P., Ammons J.T., Kotzin B.L. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes. J. Immunol. 1987, 139:1873-1879.
6. Bave U., Magnusson M., Eloranta M.L., Perers A., Alm G.V., Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol. 2003, 171:3296-3302.
7. Biggs B.A., Hewish M., Kent S., Hayes K., Crowe S.M. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J. Immunol. 1995, 154:6132-6139.
8. Boruchov A.M., Heller G., Veri M.C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 2005, 115:2914-2923.
9. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
10. Caligiuri M.A., Murray C., Robertson M.J., Wang E., Cochran K., Cameron C., Schow P., Ross M.E., Klumpp T.R., Soiffer R.J., et al. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J. Clin. Invest. 1993, 91:123-132.
11. Crowe S.M. Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust. N. Z. J. Med. 1995, 25:777-783.
12. Crowe S.M., Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 2000, 68:345-350.
13. Dall'Ozzo S., Tartas S., Paintaud G., Cartron G., Colombat P., Bardos P., Watier H., Thibault G. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res. 2004, 64:4664-4669.
14. Diamond B., Bloom B.R., Scharff M.D. The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J. Immunol. 1978, 121:1329-1333.
15. Eger K.A., Unutmaz D. Perturbation of natural killer cell function and receptors during HIV infection. Trends Microbiol. 2004, 12:301-303.
16. Forthal D.N., Landucci G., Daar E.S. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J. Virol. 2001, 75:6953-6961.
17. Grazia Cifone M., Giacomelli R., Famularo G., Paolini R., Danese C., Napolitano T., Procopio A., Perego A.M., Santoni A., Tonietti G. Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis. Clin. Exp. Immunol. 1990, 80:360-365.
18. Holl V., Hemmerter S., Burrer R., Schmidt S., Bohbot A., Aubertin A.M., Moog C. Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J. Immunol. 2004, 173:6274-6283.
19. Hu P.F., Hultin L.E., Hultin P., Hausner M.A., Hirji K., Jewett A., Bonavida B., Detels R., Giorgi J.V. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10:331-340.
20. Hulett M.D., Hogarth P.M. Molecular basis of Fc receptor function. Adv. Immunol. 1994, 57:1-127.
21. Kedzierska K., Mak J., Mijch A., Cooke I., Rainbird M., Roberts S., Paukovics G., Jolley D., Lopez A., Crowe S.M. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J. Infect. Dis. 2000, 181:390-394.
22. Kedzierska K., Mak J., Jaworowski A., Greenway A., Violo A., Chan H.T., Hocking J., Purcell D., Sullivan J.S., Mills J., Crowe S. nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS 2001, 15:945-955.
23. Kedzierska K., Ellery P., Mak J., Lewin S.R., Crowe S.M., Jaworowski A. HIV-1 down-modulates gamma signaling chain of Fc gamma R in human macrophages: a possible mechanism for inhibition of phagocytosis. J. Immunol. 2002, 168:2895-2903.
24. Kedzierska K., Azzam R., Ellery P., Mak J., Jaworowski A., Crowe S.M. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol. 2003, 26:247-263.
25. Kondo L.L., Rosenau W., Wara D.W. Role of lymphotoxin in antibody-dependent cell-mediated cytotoxicity (ADCC). J. Immunol. 1981, 126:1131-1133.
26. Laszlo A., Petri I., Ilyes M. Antibody dependent cellular cytotoxicity (ADCC)-reaction and an in vitro steroid sensitivity test of peripheral lymphocytes in children with malignant haematological and autoimmune diseases. Acta Paediatr. Hung. 1986, 27:23-29.
27. Leeansyah E., Wines B.D., Crowe S.M., Jaworowski A. The mechanism underlying defective Fcgamma receptor-mediated phagocytosis by HIV-1-infected human monocyte-derived macrophages. J. Immunol. 2007, 178:1096-1104.
28. Liu Q., Sun Y., Rihn S., Nolting A., Tsoukas P.N., Jost S., Cohen K., Walker B., Alter G. Matrix Metalloprotease inhibitors restore impaired NK cell mediated Antibody dependent cellular cytotoxicity in human immunodeficiency virus-1 infection. J. Virol. 2009.
29. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl Acad. Sci. U.S.A. 2003, 100:15011-15016.
30. Natsume A., Niwa R., Satoh M. Improving effector functions of antibodies for cancer treatment: enhancing ADCC and CDC. Drug Des. Devel. Ther. 2009, 3:7-16.
31. Nimmerjahn F., Ravetch J.V. Fc-receptors as regulators of immunity. Adv. Immunol. 2007, 96:179-204.
32. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 2008, 8:34-47.
33. Oganesyan V., Damschroder M.M., Leach W., Wu H., Dall'Acqua W.F. Structural characterization of a mutated, ADCC-enhanced human Fc fragment. Mol. Immunol. 2008, 45:1872-1882.
34. Okayama Y., Kirshenbaum A.S., Metcalfe D.D. Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: up-regulation by IFN-gamma. J. Immunol. 2000, 164:4332-4339.
35. Pereyra F., Addo M.M., Kaufmann D.E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., Ueda P., Lu Z., Cohen D., Wrin T., Petropoulos C.J., Rosenberg E.S., Walker B.D. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 2008, 197:563-571.
36. Pricop L., Redecha P., Teillaud J.L., Frey J., Fridman W.H., Sautes-Fridman C., Salmon J.E. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J. Immunol. 2001, 166:531-537.
37. Ravetch J.V., Kinet J.P. Fc receptors. Annu. Rev. Immunol. 1991, 9:457-492.
38. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., Benenson M., Gurunathan S., Tartaglia J., McNeil J.G., Francis D.P., Stablein D., Birx D.L., Chunsuttiwat S., Khamboonruang C., Thongcharoen P., Robb M.L., Michael N.L., Kunasol P., Kim J.H. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N. Engl. J. Med. 2009.
39. Richards J.O., Karki S., Lazar G.A., Chen H., Dang W., Desjarlais J.R. Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol. Cancer Ther. 2008, 7:2517-2527.
40. Shore S.L., Nahmias A.J., Starr S.E., Wood P.A., McFarlin D.E. Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature 1974, 251:350-352.
41. Siberil S., Dutertre C.A., Fridman W.H., Teillaud J.L. FcgammaR: the key to optimize therapeutic antibodies?. Crit. Rev. Oncol. Hematol. 2007, 62:26-33.
42. Szucs G., Kavai M., Suranyi P., Kiss E., Csipo I., Szegedi G. Correlations of monocyte phagocytic receptor expressions with serum immune complex level in systemic lupus erythematosus. Scand. J. Immunol. 1994, 40:481-484.
43. Tas M., Drexhage H.A., Goudsmit J. A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41. Clin. Exp. Immunol. 1988, 71:13-18.
44. Tomaras G.D., Yates N.L., Liu P., Qin L., Fouda G.G., Chavez L.L., Decamp A.C., Parks R.J., Ashley V.C., Lucas J.T., Cohen M., Eron J., Hicks C.B., Liao H.X., Self S.G., Landucci G., Forthal D.N., Weinhold K.J., Keele B.F., Hahn B.H., Greenberg M.L., Morris L., Karim S.S., Blattner W.A., Montefiori D.C., Shaw G.M., Perelson A.S., Haynes B.F. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 2008, 82:12449-12463.
45. Tridandapani S., Wardrop R., Baran C.P., Wang Y., Opalek J.M., Caligiuri M.A., Marsh C.B. TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. J. Immunol. 2003, 170:4572-4577.
46. Wahl S.M., Allen J.B., Gartner S., Orenstein J.M., Popovic M., Chenoweth D.E., Arthur L.O., Farrar W.L., Wahl L.M. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J. Immunol. 1989, 142:3553-3559.
47. Webster N.L., Kedzierska K., Azzam R., Paukovics G., Wilson J., Crowe S.M., Jaworowski A. Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection. J. Leukoc. Biol. 2006, 79:294-302.